Simultaneous targeting of Aurora kinases and Bcr-Abl kinase...

Blood 2008 / 01 Vol. 111; Iss. 8

Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I

Gontarewicz, A., Balabanov, S., Keller, G., Colombo, R., Graziano, A., Pesenti, E., Benten, D., Bokemeyer, C., Fiedler, W., Moll, J., Brummendorf, T. H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
111
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2007-09-113175
Date:
January, 2008
File:
PDF, 1.77 MB
english, 2008
Conversion to is in progress
Conversion to is failed